Skip to main content

For Patients

Get Involved with OBRI

Joining OBRI is one of the most meaningful ways you can contribute to research that helps people living with arthritis. Your real-world experiences provide insights that clinical trials simply cannot.

Your path to participation

Living with rheumatoid arthritis or psoriatic arthritis?

OBRI is a voluntary research registry for patients living with rheumatoid arthritis (RA) or psoriatic arthritis (PsA). By participating, you contribute your real-world experience to a long-term study that is shaping arthritis care across Canada.

Participation is entirely voluntary. You may withdraw at any time without any effect on your medical care.

How to get started

  1. 1Speak with your rheumatologist at your next appointment — ask whether their clinic participates in OBRI
  2. 2If eligible, review the study information and sign a consent form at your convenience

Questions?

Contact our research coordinator at Angela.Cesta@uhn.ca for more information about joining.

What to expect

Participation in OBRI is designed to be as easy and unobtrusive as possible.

Complete questionnaires

At each visit, you will fill out short questionnaires about how you are feeling, your symptoms, and your quality of life. These typically take 10–15 minutes.

Routine clinical visits

No extra appointments are required. Data is collected alongside your regular rheumatology visits, so participation fits naturally into your existing care schedule.

Your privacy is protected

All information is de-identified and stored securely. Your data will never be shared in a way that could identify you personally.

Why your participation matters

OBRI has been collecting data since 2005 and has grown to include over 3,500 patients across Ontario, British Columbia, and Alberta. The insights generated from this data have had a real and measurable impact on arthritis care.

  • Real-world data from patients like you helps researchers understand how treatments work outside of controlled clinical trial settings.
  • Findings from OBRI have directly informed treatment guidelines and clinical decision-making for rheumatoid arthritis and psoriatic arthritis across Canada.
  • Your participation helps ensure that future arthritis treatments are tested and evaluated in populations that reflect the real diversity of patients.
  • OBRI results have been presented at major international conferences and published in leading medical journals.

OBRI at a glance

3,500+

Patients enrolled

91

Participating sites

2005

Year founded

40+

Publications